Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 1 , Pages 41-47, January 2009

Neuroprosthesis for Footdrop Compared with an Ankle-Foot Orthosis: Effects on Postural Control during Walking

  • Haim Ring, MD, MSc

      Affiliations

    • Neurological Rehabilitation Department, Loewenstein Rehabilitation Center, Ranana, Israel
    • Department of Rehabilitation Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Iuly Treger, MD, PhD

      Affiliations

    • Neurological Rehabilitation Department, Loewenstein Rehabilitation Center, Ranana, Israel
    • Department of Rehabilitation Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Leor Gruendlinger, MS

      Affiliations

    • Movement Disorders Unit, Neurology Department, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
  • ,
  • Jeffrey M. Hausdorff, PhD

      Affiliations

    • Department of Physical Therapy, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
    • Movement Disorders Unit, Neurology Department, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
    • Division on Aging, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationAddress correspondence to Jeffrey M. Hausdorff, PhD, Movement Disorders Unit, Neurology Department, Tel-Aviv Sourasky Medical Center, Weizmann 6 Tel-Aviv, Israel.

Received 19 May 2008; received in revised form 17 August 2008; accepted 26 August 2008.

Objectives

We sought to compare the effects of a radio frequency–controlled neuroprosthesis on gait stability and symmetry to the effects obtained with a standard ankle-foot orthosis (AFO).

Methods

A total of 15 patients (mean age: 52.2 ± 3.6 years) with prior chronic hemiparesis resulting from stroke or traumatic brain injury (5.9 ± 1.5 year) whose walking was impaired by footdrop and regularly used an AFO participated in the study. There was a 4-week adaptation period during which participants increased their daily use of the neuroprosthesis, while using the AFO for the rest of the day. Gait was then assessed in a 6-minute walk while wearing force-sensitive insoles, by using the neuroprosthesis and the AFO in a randomized order. An additional gait assessment was conducted after using the neuroprosthesis for a further 4 weeks. Gait speed and stride time (inverse of cadence) were determined, as were gait asymmetry index and swing time variability.

Results

After the 4-week adaptation period, there were no differences between walking with the neuroprosthesis and walking with the AFO (P > .05). After 8 weeks, there was no significant difference in gait speed, whereas stride time improved from 1.48 ± 0.21 seconds with the AFO to 1.41 ± 0.16 seconds with the neuroprosthesis (P < .02). Swing time variability decreased from 5.3 ± 1.6% with the AFO to 4.3 ± 1.4% with the neuroprosthesis (P = .01). A gait asymmetry index improved by 15%, from 0.20 ± 0.09 with the AFO to 0.17 ± 0.08 with the neuroprosthesis (P < .05).

Conclusions

Compared with AFO, the studied neuroprosthesis appears to enhance balance control during walking and, thus, more effectively manage footdrop.

Key Words: Neuroprosthesis, functional electrical stimulation, ankle-foot orthosis, postural control, gait

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was funded in part by Ness Ltd, Ra'anana, Israel.

 Portions of this work were presented at the 15th International World Congress of Physical Therapy in Vancouver, British Columbia, Canada, in June 6, 2007.

PII: S1052-3057(08)00206-1

doi:10.1016/j.jstrokecerebrovasdis.2008.08.006

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 1 , Pages 41-47, January 2009